Coinbase Under SEC Probe Over Crypto Token Listings: Report

The U.S. Securities and Exchange Commission (SEC) is reportedly investigating Coinbase Global Inc (NASDAQ: COIN) for listing unregistered securities on its cryptocurrency trading platform.

The U.S. Securities and Exchange Commission (SEC) is reportedly investigating Coinbase Global Inc (NASDAQ:COIN) for listing unregistered securities on its cryptocurrency trading platform.

What Happened: According to a report from Bloomberg on Monday, three people familiar with the matter said that the SEC’s enforcement unit is looking into whether Coinbase wrongfully listed tokens that should have been registered as securities.  

The sources also said that the SEC’s inquiries began before it named nine crypto tokens as securities in an insider trading lawsuit against a former Coinbase employee and two of his associates.

See Also: Mark Cuban Warns Crypto Faces Nightmare From SEC’s Next Move: ‘Wait Till You See What They Come Up With’

“Coinbase does not list securities. Period,” said Coinbase’s chief legal officer, Paul Grewal, in a blog post earlier this week.

According to Bloomberg’s sources, who asked not to be named, the SEC began its inquiry after Coinbase began to rapidly expand the number of tokens listed on its platform.

Last year, Coinbase CEO Brian Armstrong said that the company plans to list every crypto asset where it is legal to do so.

“But in general, one should not take being listed on Coinbase as an endorsement of that asset (outside of meeting our minimum standards),” said Armstrong at the time.

Price Action: Coinbase shares slumped 5.3% to $67.07 on Monday, before falling 1.9% lower in after-market hours, according to data from Benzinga Pro. The leading digital asset Bitcoin (CRYPTO: BTC) was trading at $21,103, down 3.92% over the last 24 hours.

Read Next: So Do You Believe Bitcoin Is Going Above $40K, Ethereum Above $3K And Dogecoin Above 20 Cents By End Of 2022?

 

Total
0
Shares
Related Posts
Read More

Vistagen Announces The Two Leading Proxy Advisory Firms, Institutional Shareholder Services And Glass Lewis, Recommend Stockholders Vote “For” Proposal No. 5 To Provide Its Board With The Option To Implement A Future Reverse Stock Split, If Necessary

Vistagen Therapeutics, Inc. (NASDAQ:VTGN) (the Company), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other central

VTGN